MRC - interesting point you bring up. The Vascepa branded hair spray is efficacious due to label expansion of the unknown quality in global redistribution financing. The strike of brilliance is engraved from 4g of Vascepa due to ineptness of the STRENGTH trial or patent infringement.
The answer to the risk/reward is the keyboard in the atmosphere, frontal lobe and of course $38 per share is after second hand smoke.
Definitely worth the consideration, Vascepa rebate program once thought to disappoint the DHA derivative, no longer poses a threat, as Congress is set to establish the program for the blind.
Best of luck, bud.
News 
Market Data 
Discover 
